首页> 外文期刊>American Journal of Clinical and Experimental Medicine >Standardization of Sarasvatha Choorna: Used as a Remedy for Dementia
【24h】

Standardization of Sarasvatha Choorna: Used as a Remedy for Dementia

机译:Sarasvatha Choorna的标准化:用于痴呆症的治疗

获取原文
       

摘要

Sri Lanka has been recognized as one of the fastest aging populations from the developing countries. There is a large senior population in the country. Since age is the biggest risk factor for Dementia, the need to create awareness and management is an increasing necessity. Sarasvatha Choorna is one of the polyherbal preparation used in Ayurveda for the management of Dementia which consists of 12 medicinal plants. In the present study, an attempt was made to standardize Sarasvatha Choorna by using standard protocols. Standardization was carried out by determination of total ash, water soluble ash, acid insoluble ash, microbial counts, heavy metals, phytochemical screening and development of TLC-densitogram fingerprints. Results revealed that 10.6±0.0% of total ash, 8.4±0.0% of water soluble ash 0.65±0.01% of acid insoluble ash 11.0±0.1% of cold ethanol extractable matter, 13.9±0.1% hot ethanol extractable matter, 13.9±0.1% cold water extractable matter and 20.2±0.2% hot water extractable matter were present in the Sarasvatha Choorna. Pathogenic microorganisms such as Coliforms, Escherichia coli and Salmonella were not found and heavy metal concentrations of Sarasvatha Choorna were well below the recommended upper limits for the tested heavy metals. Phytochemical screening studies revealed the presence of flavonoids, steroid glycosides and coumarins in both water and ethanol extracts of Sarasvatha Choorna. Presence of the raw materials in the Sarasvatha Choorna was confirmed by TLC fingerprints. Present study reveals the quality of Sarasvatha Choorna for the first time and quality control parameters resulted from this study can be used as a reference standard for quality control of Sarasvatha Choorna.
机译:斯里兰卡被公认为是发展中国家老龄化最快的国家之一。该国人口众多。由于年龄是痴呆症的最大危险因素,因此越来越需要提高意识和进行管理。 Sarasvatha Choorna是阿育吠陀用于痴呆症管理的多草药制剂之一,它由12种药用植物组成。在本研究中,尝试通过使用标准协议来标准化Sarasvatha Choorna。通过测定总灰分,水溶性灰分,酸不溶性灰分,微生物数量,重金属,植物化学筛选和TLC密度图指纹图谱的开发来进行标准化。结果表明,总灰分的10.6±0.0%,水溶性灰分的8.4±0.0%,酸不溶性灰分的0.65±0.01%的冷乙醇可萃取物的11.0±0.1%,热乙醇可萃取物的13.9±0.1%,13.9±0.1% Sarasvatha Choorna中有冷水可萃取物和20.2±0.2%的热水可萃取物。未发现致病微生物,例如大肠菌,大肠杆菌和沙门氏菌,萨拉斯瓦莎·乔纳(Sarasvatha Choorna)的重金属浓度远低于建议的重金属上限。植物化学筛选研究表明,萨拉斯瓦莎·乔纳(Sarasvatha Choorna)的水和乙醇提取物中均存在类黄酮,类固醇糖苷和香豆素。 TLC指纹图谱确认了萨拉斯瓦莎·乔纳(Sarasvatha Choorna)中原料的存在。本研究首次揭示了萨拉索瓦·乔纳的质量,该研究产生的质量控制参数可以作为萨拉萨瓦·乔纳的质量控制的参考标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号